Home  /  Resource Library  /  A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88mut/CD79Bmut diffuse large B-cell lymphoma

A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88mut/CD79Bmut diffuse large B-cell lymphoma

Study investigated btk inhibitors for treatment of DLBCL.